e-learning
resources
Milan 2017
Monday, 11.09.2017
The wide spectrum of ILDs
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Diffuse pulmonary ossification in Idiopathic Pulmonary Fibrosis: Forli 10-year experience
N. Muhammad (Bandar Baru Bangi, Selangor, Malaysia)
Source:
International Congress 2017 – The wide spectrum of ILDs
Session:
The wide spectrum of ILDs
Session type:
Poster Discussion
Number:
2950
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
N. Muhammad (Bandar Baru Bangi, Selangor, Malaysia). Diffuse pulmonary ossification in Idiopathic Pulmonary Fibrosis: Forli 10-year experience. 2950
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
Is Pulmonary Rehabilitation A Savior In Idiopathic Pulmonary Fibrosis?
Source: Virtual Congress 2020 – News on diagnosis and therapy of idiopathic pulmonary fibrosis
Year: 2020
Platelet activation indices in patients with Idiopathic Pulmonary Fibrosis
Source: International Congress 2014 – ILDs 5
Year: 2014
Treatment of Idiopathic Pulmonary Fibrosis
Source: Guideline 2015
Year: 2015
Idiopathic Pulmonary Fibrosis: mortality trends in Chile
Source: International Congress 2019 – Interstitial lung disease registries
Year: 2019
Tele-rehabilitation program in Idiopathic Pulmonary Fibrosis
Source: International Congress 2019 – M-health/e-health I
Year: 2019
Pirfenidone in idiopathic pulmonary fibrosis - description of a German cohort
Source: International Congress 2014 – ILDs 4
Year: 2014
Baseline characteristics of idiopathic pulmonary fibrosis: analysis from the Australian Idiopathic Pulmonary Fibrosis Registry
Source: Eur Respir J , 49 (2) 1601592; DOI: 10.1183/13993003.01592-2016
Year: 2017
Diffuse dendriform pulmonary ossification in a usual interstitial pneumonia-like distribution: A distinct entity or a variant of idiopathic pulmonary fibrosis?
Source: International Congress 2014 – ILDs 1
Year: 2014
IPF - Idiopathic Pulmonary Fibrosis
Source: Breathe, 15 (2) 153; 10.1183/20734735.ELF152
Year: 2019
Epidemiology of Idiopathic Pulmonary Fibrosis in Australia
Source: Virtual Congress 2021 – Interstitial lung disease around the world
Year: 2021
Idiopathic Pulmonary Fibrosis (IPF)
Source: ERS Course 2019 - Interstitial Lung Diseases
Year: 2018
Idiopathic Pulmonary Fibrosis (IPF)
Source: ERS Course 2019 - Interstitial Lung Diseases
Year: 2019
Idiopathic Pulmonary Fibrosis (IPF)
Source: ERS Courses: Interstitial Lung Diseases
Year: 2019
Association between Pulmonary Infections and the Prognosis in Patients with Idiopathic Pulmonary Fibrosis
Source: Virtual Congress 2021 – Interstitial lung disease around the world
Year: 2021
Long-term survival analysis: Pirfenidone compared to standard care for the treatment of patients with idiopathic pulmonary fibrosis
Source: International Congress 2014 – Clinical trials in IPF
Year: 2014
Impact of depression on patients with Idiopathic Pulmonary Fibrosis
Source: International Congress 2017 – Best clinical practice for the management of chronic lung diseases
Year: 2017
Assessment of telomere length in the combined pulmonary fibrosis and emphysema syndrome
Source: International Congress 2014 – ILDs: diagnostic and prognostic investigations
Year: 2014
Predictors of efficacy of pirfenidone in idiopathic pulmonary fibrosis
Source: International Congress 2014 – ILDs 4
Year: 2014
Pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis: Comparison with COPD
Source: Annual Congress 2013 –Exercise, physiotherapy techniques and assessment in different chronic conditions
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept